Synapse
⌘+K
Sign In
Sign Up for Free
Synapse
Sign In
Sign Up for Free
Home
Communities
Explore
More
Language
English
English
Ixion (Spain)
h-index: 4
Total citations: 55
Total papers: 7
Homepage:
http://ixion.es/en/
Recent papers from Ixion (Spain)
Phase III Study to Confirm Clinical Similarity of MB09, a Denosumab Biosimilar, and Prolia® in Postmenopausal Women with Osteoporosis (SIMBA Study)
Pharmaceutics · 2026
Pooled analysis of three pharmacokinetic studies comparing biosimilar MB02 and reference bevacizumab
Pharmacology Research & Perspectives · 2023
A randomized, double‐blind, single‐dose study to assess bioequivalence of MB02 biosimilar after manufacturing iteration and reference bevacizumab
Pharmacology Research & Perspectives · 2023
A randomized, double blind, single dose, comparative study of the pharmacokinetics, safety and immunogenicity of MB02 (bevacizumab biosimilar) and reference bevacizumab in healthy male volunteers
British Journal of Clinical Pharmacology · 2021
Efficacy, Safety and Immunogenicity of MB02 (Bevacizumab Biosimilar) versus Reference Bevacizumab in Advanced Non-Small Cell Lung Cancer: A Randomized, Double-Blind, Phase III Study (STELLA)
BioDrugs · 2021